Auxier Asset Management’s Perspective Therapeutics CATX Stock Holding History

Auxier Asset Management’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,022	Closed	-$12.2K	–	170
2024 Q1	$12.2K	Hold	1,022	–	–	﹤0.01%	172
2023 Q4	$4.11K	Hold	1,022	–	–	﹤0.01%	173
2023 Q3	$2.8K	Hold	1,022	–	–	﹤0.01%	166
2023 Q2	$6.83K	Sell	1,022 -400	-28%	-$2.43K	﹤0.01%	165
2023 Q1	$9.07K	Hold	1,422	–	–	﹤0.01%	161
2022 Q4	$3.51K	Hold	1,422	–	–	﹤0.01%	162
2022 Q3	$3K	Hold	1,422	–	–	﹤0.01%	155
2022 Q2	$4K	Hold	1,422	–	–	﹤0.01%	161
2022 Q1	$5K	Hold	1,422	–	–	﹤0.01%	169
2021 Q4	$6K	Hold	1,422	–	–	﹤0.01%	171
2021 Q3	$9K	Hold	1,422	–	–	﹤0.01%	166
2021 Q2	$11K	Hold	1,422	–	–	﹤0.01%	164
2021 Q1	$15K	Hold	1,422	–	–	﹤0.01%	162
2020 Q4	$6K	Hold	1,422	–	–	﹤0.01%	157
2020 Q3	$8K	Hold	1,422	–	–	﹤0.01%	150
2020 Q2	$8K	Hold	1,422	–	–	﹤0.01%	147
2020 Q1	$8K	Hold	1,422	–	–	﹤0.01%	150
2019 Q4	$9K	Hold	1,422	–	–	﹤0.01%	165
2019 Q3	$5K	Hold	1,422	–	–	﹤0.01%	161
2019 Q2	$6K	Hold	1,422	–	–	﹤0.01%	163
2019 Q1	$5K	Hold	1,422	–	–	﹤0.01%	152
2018 Q4	$4K	Hold	1,422	–	–	﹤0.01%	146
2018 Q3	$7K	Hold	1,422	–	–	﹤0.01%	153
2018 Q2	$6K	Hold	1,422	–	–	﹤0.01%	152
2018 Q1	$6K	Hold	1,422	–	–	﹤0.01%	149
2017 Q4	$6K	Hold	1,422	–	–	﹤0.01%	150
2017 Q3	$7K	Hold	1,422	–	–	﹤0.01%	152
2017 Q2	$9K	Hold	1,422	–	–	﹤0.01%	153
2017 Q1	$8K	Hold	1,422	–	–	﹤0.01%	155
2016 Q4	$8K	Hold	1,422	–	–	﹤0.01%	151
2016 Q3	$10K	Hold	1,422	–	–	﹤0.01%	152
2016 Q2	$12K	Hold	1,422	–	–	﹤0.01%	146
2016 Q1	$13K	Hold	1,422	–	–	﹤0.01%	142
2015 Q4	$13K	Hold	1,422	–	–	﹤0.01%	145
2015 Q3	$20K	Hold	1,422	–	–	﹤0.01%	137
2015 Q2	$21K	Hold	1,422	–	–	﹤0.01%	141
2015 Q1	$22K	Hold	1,422	–	–	﹤0.01%	143
2014 Q4	$21K	Hold	1,422	–	–	﹤0.01%	145
2014 Q3	$24K	Hold	1,422	–	–	0.01%	146
2014 Q2	$44K	Hold	1,422	–	–	0.01%	149
2014 Q1	$31K	Buy	+1,422	New	+$14.5K	0.01%	148

Other funds holding CATX

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Auxier Asset Management's CATX Position: Q2 2024 in Review

Auxier Asset Management sold out of Perspective Therapeutics (CATX) in Q2 2024, closing a stake of 1,022 shares — an estimated $12.2K sold.

Auxier Asset Management first reported a position in CATX in Q1 2014 and held it in 41 quarters. The position peaked at $44K in Q2 2014. 105 funds tracked by Wall St. Rank hold CATX as of Q2 2024.

Auxier Asset Management reported no remaining Perspective Therapeutics position as of Q2 2024 after selling out during the quarter.
Auxier Asset Management sold 1,022 Perspective Therapeutics shares in Q2 2024, an estimated $12.2K.
Auxier Asset Management first reported a position in Perspective Therapeutics in Q1 2014 and held it in 41 quarters.
Auxier Asset Management's Perspective Therapeutics position peaked at $44K in Q2 2014.
105 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2024.

Based on Auxier Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.